1210 ABT-267 COMBINED WITH PEGYLATED INTERFERON ALPHA-2A/RIBAVIRIN IN GENOTYPE 1 (GT1) HCV-INFECTED TREATMENT-NAIVE SUBJECTS: 12 WEEK ANTIVIRAL AND SAFETY ANALYSIS
Authors:
- G.J. SullivanGSG.J. Sullivan
- M. Rodriques-TorresMRM. Rodriques-Torres
- E. LawitzELE. Lawitz
- F. PoordadFPF. Poordad
- M. KapoorMKM. Kapoor
- A. CampbellACA. Campbell
- C. SetzeCSC. Setze
- W. XieWXW. Xie
- A. KhatriAKA. Khatri
- E. DumasEDE. Dumas
- P. KrishnanPKP. Krishnan
- T. Pilot-MatiasTPT. Pilot-Matias
- 30 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 56, S480